Gastric Cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients registered as key inclusion criteria of KSES001. Concretely, cases registered as KSES001 among those of the non-preoperative therapy and Gastric cancer those with Stage I, II or III undergo R0 surgery (TG surgery or DG surgery) from September, 2011 to June, 2012.
Exclusion criteria
Exclusion criteria: There is none of new key exclusion criteria because the patients of KSES001 are selected in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of body weight loss from before the surgery to half a year and one year after the surgery, respectively. | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Area of skeletal muscle, maximum area of psoas major muscle, capacity of psoas major muscle, rate of skeletal muscle mass (corrected value) (2) Implementation status of the adjuvant chemotherapy (3) Period of duration after the adjuvant chemotherapy (4) Laboratory values (5) Existence or non-existence of relapse (6) Intake of elemental diet, oligomeric formula and polymeric formula (7) Late complications after surgery | — |
Countries
Japan
Contacts
Kindai University Surgery